NCT03611400 - The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions

Intestinal Barrier Function

Interventions

DIETARY_SUPPLEMENT

Probiotic

This probiotic is commercially available and contains L. helveticus R0052 (0.2 x 10\^9 CFU/capsule) and L. rhamnosus R0011 (3.8 x 10\^9 CFU/capsule) as active ingredients and ascorbic acid, hypromellose, magnesium stearate, saccharose, potato starch, titanium dioxide, and maltodextrin as excipients.

DIETARY_SUPPLEMENT

Placebo

The placebo contains ascorbic acid, hypromellose, magnesium stearate, saccharose, potato starch, titanium dioxide and maltodextrin.

Trial Locations (1)

32611-0370

University of Florida, Gainesville